Department of Internal Medicine and Cardiovascular Center, Seoul National University Hospital, Seoul, Republic of Korea.
Division of Cardiology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.
JACC Cardiovasc Interv. 2015 Aug 24;8(10):1318-1331. doi: 10.1016/j.jcin.2015.05.014.
The purpose of this study was to investigate the differential clinical outcomes after percutaneous coronary intervention (PCI) for coronary bifurcation lesions with 1- or 2-stenting techniques using first- or second-generation drug-eluting stents (DES).
The 2-stenting technique has been regarded to have worse clinical outcomes than the 1-stenting technique after bifurcation PCI with first-generation DES. However, there has been a paucity of data comparing the 1- and 2-stenting techniques with the use of second-generation DES.
Patient-level pooled analysis was performed with 3,162 patients undergoing PCI using first- or second-generation DES for bifurcation lesions from the "Korean Bifurcation Pooled Cohorts" (COBIS [Coronary Bifurcation Stenting] II, EXCELLENT [Registry to Evaluate Efficacy of Xience/Promus Versus Cypher in Reducing Late Loss After Stenting], and RESOLUTE-Korea [Registry to Evaluate the Efficacy of Zotarolimus-Eluting Stent]). The 3-year clinical outcomes were compared between 1- and 2-stenting techniques, stratified by the type of DES.
With first-generation DES, rates of target lesion failure (TLF) or patient-oriented composite outcome (POCO) (a composite of all death, any myocardial infarction, any repeat revascularization, and cerebrovascular accidents) at 3 years were significantly higher after the 2-stenting than the 1-stenting technique (TLF 8.6% vs. 17.5%; p < 0.001; POCO 18.1% vs. 28.5%, p < 0.001). With second-generation DES, however, there was no difference between 1- and 2-stenting techniques (TLF 5.4% vs. 5.8%; p = 0.768; POCO 11.2% vs. 12.9%; p = 0.995). The differential effects of 2-stenting technique on the prognosis according to the type of DES were also corroborated with similar results by the inverse probability weighted model. The 2-stenting technique was a significant independent predictor of TLF in first-generation DES (hazard ratio: 2.046; 95% confidence interval: 1.114 to 3.759; p < 0.001), but not in second-generation DES (hazard ratio: 0.667; 95% confidence interval: 0.247 to 1.802; p = 0.425).
Patient-level pooled analysis of 3,162 patients in Korean Bifurcation Pooled Cohorts demonstrated that the 2-stenting technique showed comparable outcomes to 1-stenting technique with second-generation DES, which is different from the results of first-generation DES favoring the 1-stenting technique.
本研究旨在探讨使用第一代或第二代药物洗脱支架(DES)进行经皮冠状动脉介入治疗(PCI)治疗冠状动脉分叉病变时,1 或 2 支架技术的临床结果差异。
第一代 DES 治疗分叉 PCI 时,2 支架技术的临床结果被认为比 1 支架技术差。然而,使用第二代 DES 比较 1 支架和 2 支架技术的临床结果的数据很少。
对“韩国分叉队列汇总分析”(COBIS [冠状动脉分叉支架] II、EXCELLENT [评价 Xience/Promus 与 Cypher 在支架置入后晚期损失减少中的疗效注册研究] 和 RESOLUTE-Korea [评价佐他莫司洗脱支架疗效的注册研究])中使用第一代或第二代 DES 治疗分叉病变的 3162 例患者进行了患者水平的汇总分析。比较了 2 种支架技术的临床结果,分层因素为 DES 类型。
在第一代 DES 中,2 支架技术的靶病变失败(TLF)或患者导向的复合结局(POCO)(所有死亡、任何心肌梗死、任何再次血运重建和脑血管意外的复合终点)发生率在 3 年时显著高于 1 支架技术(TLF 8.6% vs. 17.5%;p < 0.001;POCO 18.1% vs. 28.5%,p < 0.001)。然而,在第二代 DES 中,1 支架和 2 支架技术之间没有差异(TLF 5.4% vs. 5.8%;p = 0.768;POCO 11.2% vs. 12.9%;p = 0.995)。DES 类型对预后的 2 支架技术的不同影响也通过逆概率加权模型得到了类似的结果证实。在第一代 DES 中,2 支架技术是 TLF 的独立显著预测因子(风险比:2.046;95%置信区间:1.114 至 3.759;p < 0.001),但在第二代 DES 中并非如此(风险比:0.667;95%置信区间:0.247 至 1.802;p = 0.425)。
韩国分叉队列汇总分析的 3162 例患者的患者水平汇总分析表明,第二代 DES 治疗时,2 支架技术与 1 支架技术的结果相当,这与第一代 DES 支持 1 支架技术的结果不同。